查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193137

梅毒免疫分析診斷市場：按產品類型（分析儀,試劑盒,試劑）,技術（CLIA,ELISA）,最終用戶（血庫,診斷實驗室,醫院）分類：2021-2031全球機會分析和行業預測

Syphilis Immunoassay Diagnostics Market By Product Type (Analyzers, Kits and reagents), By Technology (CLIA, ELISA), By End User (Blood Banks, Diagnostic Labs, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 247 Pages | 商品交期: 2-3個工作天內

價格

全球梅毒免疫檢測診斷市場預計將在 2021 年達到 3.155 億美元，到 2031 年達到 4.46 億美元，2022 年至 2031 年的複合年增長率為 3.5%。

梅毒是一種通過性接觸傳播的慢性細菌感染。 梅毒是由一種叫做梅毒螺旋體的細菌引起的。 梅毒有四個階段：一期,二期,潛伏期和三期。 梅毒的第一階段發生在一個人被細菌感染後約 3 至 4 週。 梅毒的第二階段可能會導致皮疹和喉嚨痛。 梅毒潛伏期主,次症狀消失，無明顯症狀。 在第三階段，它可以導致失明,耳聾和精神狀態。 該疾病的診斷可能涉及將腦脊液作為梅毒篩查試驗。 此外，梅毒血液測試尋找針對細菌梅毒螺旋體的抗體的存在。 梅毒檢測包括梅毒T微量凝集,梅毒T顆粒凝集,梅毒T血凝,熒光密螺旋體抗體吸收（FTA-ABS）試驗,化學發光免疫測定檢測密螺旋體抗體,□免疫測定。

梅毒免疫分析診斷市場的增長是由不斷上升的社會經濟因素推動的，例如性傳播疾病和在海洛因,可卡因,興奮劑,大麻,苯二氮卓類藥物和酒精等多種藥物的影響下性交率的增加。帶來。 此外，致命梅毒感染率的上升,檢測設施的激增,檢測技術的普及以及現場檢測的可用性也在推動市場的增長。 例如，根據世界衛生組織 (WHO) 的數據，2020 年，在四種性傳播感染中：衣原體（1.29 億）,淋病（8200 萬）,梅毒（710 萬）和滴蟲（1.56 億）估計有 3.74 億人新感染了一個。 然而，新興國家缺乏個人知識預計會阻礙該市場的增長。 相反，尚未開發的新興國家的高增長機會有望為市場創造有利可圖的機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章梅毒免疫分析診斷市場，按產品類型分類

  • 概覽
    • 市場規模和預測
  • 分析器
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 試劑盒和試劑
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章梅毒免疫分析診斷市場：按技術分類

  • 概覽
    • 市場規模和預測
  • 中國國際影響評估協會
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • ELISA
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章梅毒免疫分析診斷市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 血庫
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 診斷實驗室
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 醫院
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章梅毒免疫分析診斷市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品類型
    • 北美市場規模和預測：按技術分類
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品類型
    • 歐洲市場規模和預測：按技術分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區市場規模和按產品類型預測
    • 亞太市場規模和預測：按技術分類
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品類型
    • LAMEA 市場規模和預測：按技術分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • BioRad Laboratories Inc
  • Danaher Corporation
  • BECTON DICKINSON & COMPANY
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Diasorin S.P.A
  • Abbott Laboratories
  • Fujirebio
  • BioMerieux SA
  • Shenzhen New Industries Biomedical Engineering Co. Ltd
Product Code: A15454

The global syphilis immunoassay diagnostics market was valued at $315.5 million in 2021, and is projected to reach $446.0 million by 2031, registering a CAGR of 3.5% from 2022 to 2031.

Syphilis is a chronic bacterial infection that can be transmitted through sexual contact. It is caused by a type of bacteria known as Treponema pallidum. The four stages of syphilis include primary, secondary, latent, and tertiary. The primary stage of syphilis occurs about 3 to 4 weeks after a person contracts the bacteria. Skin rashes and a sore throat may develop during the second stage of syphilis. The primary and secondary symptoms disappear, and there won't be any noticeable symptoms at the latent stage of syphilis. The tertiary stage can cause blindness, loss of hearing, and mental health conditions. The diagnosis of this disease includes the collection of spinal fluid for the screening test of syphilis. Moreover, the blood test for syphilis tests for antibodies directed at the syphilis organism (Treponema pallidum). The available tests for syphilis include the microhemagglutination assay for T pallidum, the T pallidum particle agglutination, the T pallidum hemagglutination assay, the fluorescent treponemal antibody absorbed (FTA-ABS) test, and chemoluminescence immunoassays and enzyme immunoassays that detect Treponemal antibodies.

The growth of the syphilis immunoassay diagnostics market is driven by rising in socioeconomic factors such as sexually transmitted diseases and an increase in the proportion of sex under the influence of numerous drugs such as heroin, cocaine, methamphetamine, cannabis, benzodiazepines, and alcohol. Moreover, the increase in rates of fatal syphilis infections, the surge in testing facilities, the widespread use of technology in testing, and the availability of on-the-spot testing also help in the growth of the market. For instance, according to the data from World Health Organization (WHO), there were an estimated 374 million new infections with 1 of 4 STIs like chlamydia (129 million), gonorrhea (82 million), syphilis (7.1 million), and trichomoniasis (156 million) in 2020. However, a lack of knowledge among individuals in emerging economies is expected to hinder the growth of this market. Conversely, the high growth potential in untapped emerging economies is expected to create lucrative opportunities for the market.

The global syphilis immunoassay diagnostics market is segmented based on product type, technology, end-user, and region. As per product type, the market is divided into analyzers and kits & reagents. Depending on the technology, the market is bifurcated into CLIA and ELISA. According to end users, the market is classified into blood banks, diagnostic labs, and hospitals. Region-wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the syphilis immunoassay diagnostics market analysis from 2021 to 2031 to identify the prevailing syphilis immunoassay diagnostics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the syphilis immunoassay diagnostics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global syphilis immunoassay diagnostics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Analyzers
  • Kits and reagents

By Technology

  • CLIA
  • ELISA

By End User

  • Blood Banks
  • Diagnostic Labs
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • BioRad Laboratories Inc
    • Danaher Corporation
    • BECTON DICKINSON & COMPANY
    • , F. Hoffmann-La Roche AG
    • Siemens Healthineers AG
    • Diasorin S.P.A
    • Abbott Laboratories
    • Fujirebio
    • , BioMerieux SA
    • Shenzhen New Industries Biomedical Engineering Co. Ltd

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Analyzers
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Kits and reagents
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 CLIA
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 ELISA
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Blood Banks
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Diagnostic Labs
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Hospitals
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Technology
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Technology
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Technology
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Technology
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Technology
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Technology
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Technology
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Technology
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Technology
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Technology
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Technology
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Technology
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Technology
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Technology
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Technology
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Technology
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Technology
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Technology
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Technology
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Technology
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Technology
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Technology
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Technology
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 BioRad Laboratories Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Danaher Corporation
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 BECTON DICKINSON & COMPANY
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 , F. Hoffmann-La Roche AG
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Siemens Healthineers AG
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Diasorin S.P.A
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Abbott Laboratories
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Fujirebio
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 , BioMerieux SA
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Shenzhen New Industries Biomedical Engineering Co. Ltd
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ANALYZERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ANALYZERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR KITS AND REAGENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR KITS AND REAGENTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR CLIA, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR CLIA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ELISA, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR ELISA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR BLOOD BANKS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR BLOOD BANKS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92.BIORAD LABORATORIES INC: COMPANY SNAPSHOT
  • TABLE 93.BIORAD LABORATORIES INC: OPERATING SEGMENTS
  • TABLE 94.BIORAD LABORATORIES INC: PRODUCT PORTFOLIO
  • TABLE 95.BIORAD LABORATORIES INC: NET SALES
  • TABLE 96.BIORAD LABORATORIES INC: KEY STRATERGIES
  • TABLE 97.DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 98.DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 99.DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 100.DANAHER CORPORATION: NET SALES
  • TABLE 101.DANAHER CORPORATION: KEY STRATERGIES
  • TABLE 102.BECTON DICKINSON & COMPANY: COMPANY SNAPSHOT
  • TABLE 103.BECTON DICKINSON & COMPANY: OPERATING SEGMENTS
  • TABLE 104.BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
  • TABLE 105.BECTON DICKINSON & COMPANY: NET SALES
  • TABLE 106.BECTON DICKINSON & COMPANY: KEY STRATERGIES
  • TABLE 107., F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
  • TABLE 108., F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
  • TABLE 109., F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
  • TABLE 110., F. HOFFMANN-LA ROCHE AG: NET SALES
  • TABLE 111., F. HOFFMANN-LA ROCHE AG: KEY STRATERGIES
  • TABLE 112.SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • TABLE 113.SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
  • TABLE 114.SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
  • TABLE 115.SIEMENS HEALTHINEERS AG: NET SALES
  • TABLE 116.SIEMENS HEALTHINEERS AG: KEY STRATERGIES
  • TABLE 117.DIASORIN S.P.A: COMPANY SNAPSHOT
  • TABLE 118.DIASORIN S.P.A: OPERATING SEGMENTS
  • TABLE 119.DIASORIN S.P.A: PRODUCT PORTFOLIO
  • TABLE 120.DIASORIN S.P.A: NET SALES
  • TABLE 121.DIASORIN S.P.A: KEY STRATERGIES
  • TABLE 122.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 123.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 124.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 125.ABBOTT LABORATORIES: NET SALES
  • TABLE 126.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 127.FUJIREBIO: COMPANY SNAPSHOT
  • TABLE 128.FUJIREBIO: OPERATING SEGMENTS
  • TABLE 129.FUJIREBIO: PRODUCT PORTFOLIO
  • TABLE 130.FUJIREBIO: NET SALES
  • TABLE 131.FUJIREBIO: KEY STRATERGIES
  • TABLE 132., BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 133., BIOMERIEUX SA: OPERATING SEGMENTS
  • TABLE 134., BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 135., BIOMERIEUX SA: NET SALES
  • TABLE 136., BIOMERIEUX SA: KEY STRATERGIES
  • TABLE 137.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: COMPANY SNAPSHOT
  • TABLE 138.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: OPERATING SEGMENTS
  • TABLE 139.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: PRODUCT PORTFOLIO
  • TABLE 140.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: NET SALES
  • TABLE 141.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 2.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031
  • FIGURE 3.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANALYZERS SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF KITS AND REAGENTS SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 15.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,BY TECHNOLOGY,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CLIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ELISA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 18.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,BY END USER,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF BLOOD BANKS SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABS SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031(%)
  • FIGURE 22.SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET BY REGION,2021
  • FIGURE 23.U.S. SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 24.CANADA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 25.MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 26.GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 27.FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 28.UK SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 29.ITALY SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 30.SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 31.REST OF EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 32.JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 33.CHINA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 34.AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 35.INDIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 36.SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 38.BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 39.SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF LAMEA SYPHILIS IMMUNOASSAY DIAGNOSTICS MARKET,2021-2031($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46.COMPETITIVE DASHBOARD
  • FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 48.BIORAD LABORATORIES INC.: NET SALES ($MILLION)
  • FIGURE 49.DANAHER CORPORATION.: NET SALES ($MILLION)
  • FIGURE 50.BECTON DICKINSON & COMPANY.: NET SALES ($MILLION)
  • FIGURE 51., F. HOFFMANN-LA ROCHE AG.: NET SALES ($MILLION)
  • FIGURE 52.SIEMENS HEALTHINEERS AG.: NET SALES ($MILLION)
  • FIGURE 53.DIASORIN S.P.A.: NET SALES ($MILLION)
  • FIGURE 54.ABBOTT LABORATORIES.: NET SALES ($MILLION)
  • FIGURE 55.FUJIREBIO.: NET SALES ($MILLION)
  • FIGURE 56., BIOMERIEUX SA.: NET SALES ($MILLION)
  • FIGURE 57.SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD.: NET SALES ($MILLION)